Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Identification and characterization of immunogenic neoantigens in biliary cancer (BC) and pancreatic cancer (PC).
Authors
Francesca Battaglin
Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA
Francesca Battaglin , Andrew Elliott , Joanne Xiu , Sandra Algaze , Jingyuan Wang , Priya Jayachandran , Shivani Soni , Karam Ashouri , Alexandra Wong , Pooja Mittal , Jae Ho Lo , Lesly Torres-Gonzalez , Wu Zhang , Benjamin Adam Weinberg , Sanjay Goel , Emil Lou , Anthony B. El-Khoueiry , Heinz-Josef Lenz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 552)
DOI
10.1200/JCO.2024.42.3_suppl.552
Abstract #
552
Poster Bd #
F19
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Identification and characterization of immunogenic neoantigens in colorectal cancer (CRC).
First Author: Francesca Battaglin
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Genomic and immune landscape of biliary tract cancers with ARID1A, PBRM1, and BAP1 alterations.
First Author: Gentry Teng King
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox
Poster
2023 ASCO Annual Meeting
Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.
First Author: Subotheni Thavaneswaran